No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.
<h4>Background</h4>Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataplexy, is strongly associated with a genetic marker, human leukocyte antigen (HLA) DQB1*06:02. A sudden increase in the incidence of childhood narcolepsy was observed after vaccination...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/bc57afbba58049b8bf802992379f10b8 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:bc57afbba58049b8bf802992379f10b8 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:bc57afbba58049b8bf802992379f10b82021-11-18T09:00:41ZNo serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.1932-620310.1371/journal.pone.0068402https://doaj.org/article/bc57afbba58049b8bf802992379f10b82013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23950869/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataplexy, is strongly associated with a genetic marker, human leukocyte antigen (HLA) DQB1*06:02. A sudden increase in the incidence of childhood narcolepsy was observed after vaccination with AS03-adjuvanted Pandemrix influenza vaccine in Finland at the beginning of 2010. Here, we analysed whether the coinciding influenza A H1N1pdm pandemic contributed, together with the Pandemrix vaccination, to the increased incidence of childhood narcolepsy in 2010. The analysis was based on the presence or absence of antibody response against non-structural protein 1 (NS1) from H1N1pdm09 virus, which was not a component of Pandemrix vaccine.<h4>Methods</h4>Non-structural (NS) 1 proteins from recombinant influenza A/Udorn/72 (H3N2) and influenza A/Finland/554/09 (H1N1pdm09) viruses were purified and used in Western blot analysis to determine specific antibody responses in human sera. The sera were obtained from 45 patients who fell ill with narcolepsy after vaccination with AS03-adjuvanted Pandemrix at the end of 2009, and from controls.<h4>Findings</h4>Based on quantitative Western blot analysis, only two of the 45 (4.4%) Pandemrix-vaccinated narcoleptic patients showed specific antibody response against the NS1 protein from the H1N1pdm09 virus, indicating past infection with the H1N1pdm09 virus. Instead, paired serum samples from patients, who suffered from a laboratory confirmed H1N1pdm09 infection, showed high levels or diagnostic rises (96%) in H1N1pdm virus NS1-specific antibodies and very high cross-reactivity to H3N2 subtype influenza A virus NS1 protein.<h4>Conclusion</h4>Based on our findings, it is unlikely that H1N1pdm09 virus infection contributed to a sudden increase in the incidence of childhood narcolepsy observed in Finland in 2010 after AS03-adjuvanted Pandemrix vaccination.Krister MelénMarkku PartinenJanne TynellMaarit SillanpääSari-Leena HimanenOuti Saarenpää-HeikkiläChrister HublinPäivi OlsenJorma IlonenHanna NohynekRitva SyrjänenTerhi KilpiArja VuorelaTurkka KirjavainenOuti VaaralaIlkka JulkunenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 8, p e68402 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Krister Melén Markku Partinen Janne Tynell Maarit Sillanpää Sari-Leena Himanen Outi Saarenpää-Heikkilä Christer Hublin Päivi Olsen Jorma Ilonen Hanna Nohynek Ritva Syrjänen Terhi Kilpi Arja Vuorela Turkka Kirjavainen Outi Vaarala Ilkka Julkunen No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. |
| description |
<h4>Background</h4>Narcolepsy cataplexy syndrome, characterised by excessive daytime sleepiness and cataplexy, is strongly associated with a genetic marker, human leukocyte antigen (HLA) DQB1*06:02. A sudden increase in the incidence of childhood narcolepsy was observed after vaccination with AS03-adjuvanted Pandemrix influenza vaccine in Finland at the beginning of 2010. Here, we analysed whether the coinciding influenza A H1N1pdm pandemic contributed, together with the Pandemrix vaccination, to the increased incidence of childhood narcolepsy in 2010. The analysis was based on the presence or absence of antibody response against non-structural protein 1 (NS1) from H1N1pdm09 virus, which was not a component of Pandemrix vaccine.<h4>Methods</h4>Non-structural (NS) 1 proteins from recombinant influenza A/Udorn/72 (H3N2) and influenza A/Finland/554/09 (H1N1pdm09) viruses were purified and used in Western blot analysis to determine specific antibody responses in human sera. The sera were obtained from 45 patients who fell ill with narcolepsy after vaccination with AS03-adjuvanted Pandemrix at the end of 2009, and from controls.<h4>Findings</h4>Based on quantitative Western blot analysis, only two of the 45 (4.4%) Pandemrix-vaccinated narcoleptic patients showed specific antibody response against the NS1 protein from the H1N1pdm09 virus, indicating past infection with the H1N1pdm09 virus. Instead, paired serum samples from patients, who suffered from a laboratory confirmed H1N1pdm09 infection, showed high levels or diagnostic rises (96%) in H1N1pdm virus NS1-specific antibodies and very high cross-reactivity to H3N2 subtype influenza A virus NS1 protein.<h4>Conclusion</h4>Based on our findings, it is unlikely that H1N1pdm09 virus infection contributed to a sudden increase in the incidence of childhood narcolepsy observed in Finland in 2010 after AS03-adjuvanted Pandemrix vaccination. |
| format |
article |
| author |
Krister Melén Markku Partinen Janne Tynell Maarit Sillanpää Sari-Leena Himanen Outi Saarenpää-Heikkilä Christer Hublin Päivi Olsen Jorma Ilonen Hanna Nohynek Ritva Syrjänen Terhi Kilpi Arja Vuorela Turkka Kirjavainen Outi Vaarala Ilkka Julkunen |
| author_facet |
Krister Melén Markku Partinen Janne Tynell Maarit Sillanpää Sari-Leena Himanen Outi Saarenpää-Heikkilä Christer Hublin Päivi Olsen Jorma Ilonen Hanna Nohynek Ritva Syrjänen Terhi Kilpi Arja Vuorela Turkka Kirjavainen Outi Vaarala Ilkka Julkunen |
| author_sort |
Krister Melén |
| title |
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. |
| title_short |
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. |
| title_full |
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. |
| title_fullStr |
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. |
| title_full_unstemmed |
No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. |
| title_sort |
no serological evidence of influenza a h1n1pdm09 virus infection as a contributing factor in childhood narcolepsy after pandemrix vaccination campaign in finland. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/bc57afbba58049b8bf802992379f10b8 |
| work_keys_str_mv |
AT kristermelen noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT markkupartinen noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT jannetynell noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT maaritsillanpaa noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT sarileenahimanen noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT outisaarenpaaheikkila noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT christerhublin noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT paiviolsen noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT jormailonen noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT hannanohynek noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT ritvasyrjanen noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT terhikilpi noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT arjavuorela noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT turkkakirjavainen noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT outivaarala noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland AT ilkkajulkunen noserologicalevidenceofinfluenzaah1n1pdm09virusinfectionasacontributingfactorinchildhoodnarcolepsyafterpandemrixvaccinationcampaigninfinland |
| _version_ |
1718421046141386752 |